Gotham Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Gotham Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-9,102	Closed	-$248K	–	1251
2020 Q1	$248K	Buy	+9,102	New	+$253K	0.01%	886
2019 Q4	–	Sell	-20,117	Closed	-$261K	–	1268
2019 Q3	$261K	Buy	+20,117	New	+$243K	﹤0.01%	948
2016 Q1	–	Sell	-29,242	Closed	-$434K	–	1108
2015 Q4	$434K	Sell	29,242 -110	-0.4%	-$1.84K	﹤0.01%	714
2015 Q3	$482K	Buy	+29,352	New	+$601K	﹤0.01%	732
2015 Q2	–	Sell	-14,216	Closed	-$216K	–	1082
2015 Q1	$216K	Buy	+14,216	New	+$185K	﹤0.01%	858

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Gotham Asset Management's MNTA Position: Q2 2020 in Review

Gotham Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2020, closing a stake of 9,102 shares — an estimated $248K sold.

Gotham Asset Management first reported a position in MNTA in Q1 2015 and held it in 5 quarters. The position peaked at $482K in Q3 2015. 237 funds tracked by Wall St. Rank hold MNTA as of Q2 2020.

Gotham Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
Gotham Asset Management sold 9,102 Momenta Pharmaceuticals, Inc. shares in Q2 2020, an estimated $248K.
Gotham Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2015 and held it in 5 quarters.
Gotham Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $482K in Q3 2015.
237 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2020.

Based on Gotham Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.